NCM
BIIB icon

Next Capital Management’s Biogen BIIB Stock Holding History

Next Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-75
Closed -$17K – 104
2019
Q3 		$17K Sell
75
-76
-50% -$17.7K 0.01% 203
2019
Q2 		$35K Buy
151
+76
+101% +$17.5K 0.02% 194
2019
Q1 		$18K Buy
75
+50
+200% +$15.7K 0.02% 196
2018
Q4 		$8K Buy
+25
New +$7.98K 0.01% 206

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Next Capital Management's BIIB Position: Q4 2019 in Review

Next Capital Management sold out of Biogen (BIIB) in Q4 2019, closing a stake of 75 shares — an estimated $17K sold.

Next Capital Management first reported a position in BIIB in Q4 2018 and held it in 4 quarters. The position peaked at $35K in Q2 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Next Capital Management reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Next Capital Management sold 75 Biogen shares in Q4 2019, an estimated $17K.
  • Next Capital Management first reported a position in Biogen in Q4 2018 and held it in 4 quarters.
  • Next Capital Management's Biogen position peaked at $35K in Q2 2019.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Next Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.